Anixa Biosciences Company
Anixa Biosciences develops and acquires patented technologies for the purposes of patent monetization and patent assertion.
Industry:
CAR-T
Last Funding Type:
Grant
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Total Funding:
34265000
Investors Number:
1
Headquarters:
Melville, New York, United States
Last Funding Date:
2021-05-26
Founded Date:
1982-01-01